SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Century Therapeutics CNTY-813 nonclinical data at EASD 2026

Century Therapeutics said CNTY-813 demonstrated continued advancement toward the clinic via nonclinical data presented at EASD 2026.

IPSC